Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible

Simon N Rogers

Research output: Contribution to journalArticle

Abstract

Article Title and Bibliographic Information A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, et al. Support Care Cancer. 2010 Mar 25. [Epub ahead of print.] Reviewer Simon N. Rogers, FDS, RCS, FRCS, MD Purpose/Question What is the evidence in support of different management strategies for salivary gland hypofunction and xerostomia caused by cancer treatments? Source of Funding Information not available Type of Study/Design Systematic review Level of Evidence Level 1: Good-quality, patient-oriented evidence Strength of Recommendation Grade Grade A: Consistent, good-quality patient-oriented evidence
Original languageEnglish
Pages (from-to)147-149
JournalJournal of Evidence-Based Dental Practice
Volume10
Issue number3
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Xerostomia
Radiotherapy
Randomized Controlled Trials
Salivary Glands
Mars
Neoplasms
Therapeutics
Economics

Cite this

@article{86ae7fad53ed47f19d16a3fc163b61cb,
title = "Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible",
abstract = "Article Title and Bibliographic Information A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, et al. Support Care Cancer. 2010 Mar 25. [Epub ahead of print.] Reviewer Simon N. Rogers, FDS, RCS, FRCS, MD Purpose/Question What is the evidence in support of different management strategies for salivary gland hypofunction and xerostomia caused by cancer treatments? Source of Funding Information not available Type of Study/Design Systematic review Level of Evidence Level 1: Good-quality, patient-oriented evidence Strength of Recommendation Grade Grade A: Consistent, good-quality patient-oriented evidence",
author = "Rogers, {Simon N}",
year = "2010",
month = "3",
doi = "10.1016/j.jebdp.2010.06.005",
language = "English",
volume = "10",
pages = "147--149",
journal = "Journal of Evidence-Based Dental Practice",
issn = "1532-3382",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible

AU - Rogers, Simon N

PY - 2010/3

Y1 - 2010/3

N2 - Article Title and Bibliographic Information A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, et al. Support Care Cancer. 2010 Mar 25. [Epub ahead of print.] Reviewer Simon N. Rogers, FDS, RCS, FRCS, MD Purpose/Question What is the evidence in support of different management strategies for salivary gland hypofunction and xerostomia caused by cancer treatments? Source of Funding Information not available Type of Study/Design Systematic review Level of Evidence Level 1: Good-quality, patient-oriented evidence Strength of Recommendation Grade Grade A: Consistent, good-quality patient-oriented evidence

AB - Article Title and Bibliographic Information A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, et al. Support Care Cancer. 2010 Mar 25. [Epub ahead of print.] Reviewer Simon N. Rogers, FDS, RCS, FRCS, MD Purpose/Question What is the evidence in support of different management strategies for salivary gland hypofunction and xerostomia caused by cancer treatments? Source of Funding Information not available Type of Study/Design Systematic review Level of Evidence Level 1: Good-quality, patient-oriented evidence Strength of Recommendation Grade Grade A: Consistent, good-quality patient-oriented evidence

U2 - 10.1016/j.jebdp.2010.06.005

DO - 10.1016/j.jebdp.2010.06.005

M3 - Article

VL - 10

SP - 147

EP - 149

JO - Journal of Evidence-Based Dental Practice

JF - Journal of Evidence-Based Dental Practice

SN - 1532-3382

IS - 3

ER -